Nanomedicines for the treatment of tuberculosis
Mycobacterium tuberculosis (Mtb) is the bacterium responsible for the human disease tuberculosis (TB). This study aimed to develop a rapid, low cost assay for screening the anti-mycobacterial properties of new therapies. This assay employed a Green Fluorescent Protein reporter strain of Mycobacterui...
Main Author: | |
---|---|
Other Authors: | |
Published: |
Heriot-Watt University
2016
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.700539 |